骨骼和软组织病理学2023年的新进展:分子检测指南。

IF 1.7 Q3 PATHOLOGY

Journal of Pathology and Translational Medicine Pub Date : 2023-05-01 DOI:10.4132/jptm.2023.03.20

Farres Obeidin

引用次数: 0

摘要

由于现代分子技术的发展，我们对骨骼和软组织肿瘤的理解已经彻底进化。DNA和RNA测序方法在肉瘤病理中起着重要的诊断和治疗作用。在此，我们讨论了骨和软组织肿瘤分子检测的当前指南和最佳实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

What's new in bone and soft tissue pathology 2023: guidelines for molecular testing.

查看原文本刊更多论文

What's new in bone and soft tissue pathology 2023: guidelines for molecular testing.

Our understanding of bone and soft tissue tumors has thoroughly evolved as a consequence of modern molecular techniques. DNA and RNA sequencing methods play an important diagnostic and therapeutic role in sarcoma pathology. Herein, we discuss current guidelines and best practices for molecular testing in bone and soft tissue tumors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Pathology and Translational Medicine PATHOLOGY-

CiteScore

5.00

自引率

4.20%

发文量

审稿时长

14 weeks

期刊介绍： The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The categories of manuscript include original articles, review and perspective articles, case studies, brief case reports, and letters to the editor.